Getting Candid About Lung Cancer Diagnosis in the Age of COVID-19

The COVID-19 pandemic has caused a significant disruption in cancer care and treatment.1 As the leading cause of cancer death in the US, the potential impact on lung cancer is especially alarming.2,3 Recent studies predict a significant increase in the number of cancer deaths over the next five years due to missed screenings, delays in diagnosis and reductions in oncology care caused by COVID-19.3,4 While part of this disruption is due to the reduction and suspension of screening programs and diagnostic services caused by the reallocation of medical staff and…